Skip to Content

Algorae Pharmaceuticals Ltd LVCLF

Morningstar Rating
$0.00 0.00 (16.22%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

LVCLF is trading at a 51% discount.
Price
$0.00
Fair Value
$5.44
Uncertainty
Extreme
1-Star Price
$1.14
5-Star Price
$2.49
Economic Moat
Kcdl
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if LVCLF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.01
Bid/Ask
$0.00 / $0.02
Market Cap
$7.14 Mil
Volume/Avg
250 / 13,470

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Algorae Pharmaceuticals Ltd is a clinical-stage pharmaceutical company developing transformative solutions for undermet medical needs in the community. The firm develops AlgoraeOS, a closed-loop platform, leveraging computational tools to generate novel insights in silico that are being developed to initiate or accelerate therapeutic programs. Its lead products comprise AI-116, a novel combination drug candidate of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. It is conceptualised to be a potential treatment for dementia, including Alzheimer’s disease; NTCELL is an alginate-coated capsule containing clusters of neonatal porcine choroid plexus cells. It also offers LP-003 Anti-obesity Drug and LC-002 migraine treatment.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
48

Valuation

Metric
LVCLF
Price/Earnings (Normalized)
Price/Book Value
2.32
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
LVCLF
Quick Ratio
9.35
Current Ratio
9.35
Interest Coverage
Quick Ratio
LVCLF

Profitability

Metric
LVCLF
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
LVCLF
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRTxp$550.2 Bil
VRTX
Vertex Pharmaceuticals IncCjspz$111.1 Bil
REGN
Regeneron Pharmaceuticals IncHwwgfzv$107.7 Bil
MRNA
Moderna IncXvtw$36.9 Bil
ARGX
argenx SE ADRBmyw$24.2 Bil
BNTX
BioNTech SE ADRDxsz$22.3 Bil
ALNY
Alnylam Pharmaceuticals IncWblhgq$19.9 Bil
BMRN
Biomarin Pharmaceutical IncFfzwhz$17.2 Bil
RPRX
Royalty Pharma PLC Class AScjwv$13.9 Bil
INCY
Incyte CorpPyswbg$13.6 Bil

Sponsor Center